BXP, Inc. remains a buy as occupancy and portfolio quality improve, with a clear FFO growth inflection expected in H2 2026.

Leading individual contributors to the Fund’s relative performance included Axogen, Inc., a holding within the health-care ...

Having raised its distribution for 27 consecutive years, Enterprise Products Partners is an all-weather, core holding in my ...

Agency mREITs shift from deep value to momentum as 2026 rates fall. Click more on our picks, Annaly Capital Management, Inc. ...

The Voya Infrastructure, Industrials and Materials Fund (IDE) offers an 8.99% yield by investing in infrastructure, materials ...

IDEXX beat Q4 expectations, but weak vet visit trends and softer guidance pressured shares. Click here to find out why IDXX ...

Market leadership is shifting from AI to hard assets and scarcity-driven sectors like energy, infrastructure, and industrials ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...

Toyota Motor is planning a roughly 30% increase in production of hybrid and plug-in hybrid vehicles by 2028. The Japanese ...

You can provide a way better UX than this when your app throws errors by providing your own ErrorBoundary or errorElement ...

Expecting higher growth for 2026, any further upside will likely depend on the company continuing to execute. If so, I ...

Palantir is delivering exceptional, margin-accretive growth as AIP and Foundry displace traditional enterprise software and ...